(Q44151258)

30 November 2017

title

High-affinity urokinase-derived cyclic peptides inhibiting urokinase/urokinase receptor-interaction: effects on tumor growth and spread (English)

1 reference

30 November 2017

0 references

Sumito Sato

1

1 reference

30 November 2017

Charlotte Kopitz

2

1 reference

30 November 2017

Wolfgang A Schmalix

3

1 reference

30 November 2017

Bernd Muehlenweg

4

1 reference

30 November 2017

Horst Kessler

5

1 reference

30 November 2017

Manfred Schmitt

6

1 reference

30 November 2017

Achim Krüger

7

1 reference

30 November 2017

Viktor Magdolen

8

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

528

1 reference

30 November 2017

issue

1-3

1 reference

30 November 2017

page(s)

212-216

1 reference

describes a project that uses

30 November 2017

OV-MZ-6#8

0 references

cites work

The plasminogen activation system in tumor growth, invasion, and metastasis

1 reference

https://api.crossref.org/works/10.1016/S0014-5793(02)03311-2

Interference with the urokinase plasminogen activator system: a promising therapy concept for solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S0014-5793(02)03311-2

Multiple pathways of cell invasion are regulated by multiple families of serine proteases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S0014-5793(02)03311-2

uPA-silica-Particles (SP-uPA): a novel analytical system to investigate uPA-uPAR interaction and to test synthetic uPAR antagonists as potential cancer therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S0014-5793(02)03311-2

Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S0014-5793(02)03311-2

Establishment of new ovarian and colon carcinoma cell lines: differentiation is only possible by cytokeratin analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S0014-5793(02)03311-2

Urokinase induces proliferation of human ovarian cancer cells: characterization of structural elements required for growth factor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S0014-5793(02)03311-2

Structural analysis of the interaction between urokinase-type plasminogen activator and its receptor: a potential target for anti-invasive cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S0014-5793(02)03311-2

Prevention of metastasis by inhibition of the urokinase receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S0014-5793(02)03311-2

Adenoviral expression of a urokinase receptor-targeted protease inhibitor inhibits neointima formation in murine and human blood vessels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S0014-5793(02)03311-2

A bifunctional hybrid molecule of the amino‐terminal fragment of urokinase and domain II of bikunin efficiently inhibits tumor cell invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S0014-5793(02)03311-2

High-affinity urokinase receptor antagonists identified with bacteriophage peptide display

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S0014-5793(02)03311-2

Peptide-derived antagonists of the urokinase receptor. affinity maturation by combinatorial chemistry, identification of functional epitopes, and inhibitory effect on cancer cell intravasation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S0014-5793(02)03311-2

Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016/S0014-5793(02)03311-2

Scattered micrometastases visualized at the single-cell level: detection and re-isolation of lacZ-labeled metastasized lymphoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-5793(02)03311-2

Urokinase receptor antagonists: discovery and application to in vivo models of tumor growth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-5793(02)03311-2

The uPA/uPA receptor system as a target for tumor therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-5793(02)03311-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-5793(02)03311-2

1 reference

30 November 2017

1 reference